Saxony Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Sell
3,101
-170
-5% -$13.7K 0.11% 148
2026
Q1
$283K Buy
3,271
+185
+6% +$17.7K 0.16% 115
2025
Q4
$296K Buy
3,086
+40
+1% +$3.88K 0.18% 110
2025
Q3
$290K Buy
3,046
+112
+4% +$10.3K 0.19% 107
2025
Q2
$256K Buy
2,934
+178
+6% +$15.1K 0.2% 105
2025
Q1
$248K Buy
2,756
+208
+8% +$18.6K 0.22% 96
2024
Q4
$204K Sell
2,548
-49
-2% -$4.24K 0.18% 125
2024
Q3
$234K Buy
2,597
+16
+0.6% +$1.35K 0.21% 113
2024
Q2
$203K Sell
2,581
-10
-0.4% -$820 0.22% 115
2024
Q1
$226K Buy
2,591
+68
+3% +$5.8K 0.27% 94
2023
Q4
$208K Buy
+2,523
New +$192K 0.28% 94

Other funds holding MDT

Saxony Capital Management's MDT Position: Q2 2026 in Review

Saxony Capital Management reduced its Medtronic (MDT) stake by 5.2% in Q2 2026, selling an estimated $13.7K and leaving 3,101 shares worth $243K. The position accounts for 0.11% of the portfolio, ranked #148.

Saxony Capital Management first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $296K in Q4 2025. 545 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Saxony Capital Management held 3,101 shares of Medtronic worth $243K as of Q2 2026.
  • Saxony Capital Management sold 170 Medtronic shares in Q2 2026, an estimated $13.7K.
  • Medtronic made up 0.11% of Saxony Capital Management's portfolio in Q2 2026, its #148 holding.
  • Saxony Capital Management first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Saxony Capital Management's Medtronic position peaked at $296K in Q4 2025.
  • 545 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Saxony Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.